# FDA Inspection 1238101 - Cleveland Clinic Mercy Hospital - April 25, 2024

Source: https://www.keypedia.com/records/fda_inspections/cleveland-clinic-mercy-hospital/3cf06ce0-e830-41eb-bea8-c0fa0e1237dd
Source feed: FDA_Inspections

> FDA Inspection 1238101 for Cleveland Clinic Mercy Hospital on April 25, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1238101
- Company Name: Cleveland Clinic Mercy Hospital
- Inspection Date: 2024-04-25
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1163363 - 2022-02-17](https://www.keypedia.com/records/fda_inspections/cleveland-clinic-mercy-hospital/6be23070-c8f2-458a-a87c-814c4a52b399)
- [FDA Inspection 1163363 - 2022-02-17](https://www.keypedia.com/records/fda_inspections/cleveland-clinic-mercy-hospital/3cf71ee8-e93e-4d79-8454-7b01ec06cefd)
- [FDA Inspection 1070001 - 2018-10-11](https://www.keypedia.com/records/fda_inspections/cleveland-clinic-mercy-hospital/cb817a11-4532-45f1-b6d8-e3d640f58eab)
- [FDA Inspection 988944 - 2016-10-25](https://www.keypedia.com/records/fda_inspections/cleveland-clinic-mercy-hospital/e04eddc7-cf26-42ef-981a-5d4b772e7409)
- [FDA Inspection 900582 - 2014-10-21](https://www.keypedia.com/records/fda_inspections/cleveland-clinic-mercy-hospital/e69a665f-b4cb-4d5a-80b3-fc310ddac89c)

Company: https://www.keypedia.com/companies/cleveland-clinic-mercy-hospital/9e29d28a-e873-40fc-bb38-15adf4a817d3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d